Measles virus

Area of Science:

• Virology
• Immunology
• Vaccinology

Background:

• Measles virus (MV) historically caused significant morbidity and mortality.
• Live attenuated MV vaccines reduced disease severity but failed to eradicate measles.
• Continued measles outbreaks highlight the need for improved control strategies.

Purpose of the Study:

• To review the advancements in measles virus (MV) research enabled by molecular biology.
• To explore the potential of MV as a vector for novel vaccines and therapeutics.
• To discuss the future prospects of MV-based recombinant strategies.

Main Methods:

• Review of literature on MV biology, pathogenesis, and vaccine development.
• Analysis of molecular techniques, including cDNA rescue of MV.
• Evaluation of recombinant MV vector applications.

Main Results:

• Molecular biology techniques have provided deep insights into MV biology and pathogenesis.
• Novel vaccine candidates inducing immunity against measles and other pathogens have been developed.
• MV shows promise as a platform for recombinant vaccines and therapeutic vectors.

Conclusions:

• Despite vaccination, measles remains a global health concern.
• Molecular advancements have opened new avenues for measles control.
• Recombinant MV holds significant potential for future vaccine and therapeutic applications.